A clinical investigation on the possible effects of benzydamine hydrochloride on liver function.
D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy* / Q000201:enzymology; D006547:Hernia / Q000503:physiopathology; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000032:analysis; D007931:Leucyl Aminopeptidase / Q000097:blood; D008099:Liver / Q000187:drug effects*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000188:drug therapy / Q000201:enzymology; D010439:Peptic Ulcer Perforation / Q000188:drug therapy / Q000201:enzymology; D013268:Stimulation, Chemical
D000893:Anti-Inflammatory Agents; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D007931:Leucyl Aminopeptidase; D001663:Bilirubin